Evidence map›Paper›PMID 39349528›Full record

ArticleScientific reports2024

Design, synthesis, in vitro and in silico studies of novel piperidine derived thiosemicarbazones as inhibitors of dihydrofolate reductase.

Hina Aftab, Saeed Ullah, Ajmal Khan, Mariya Al-Rashida, Talha Islam, Kholood A Dahlous, Saikh Mohammad, Hamdy Kashtoh, Ahmed Al-Harrasi, Zahid Shafiq

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Hina AftabInstitute of Chemical Sciences, Bahauddin Zakariya University, Multan, 60800, Pakistan.
Saeed UllahNatural and Medical Sciences Research Centre, University of Nizwa, Birkat Al Mauz, P.O. Box 33, Nizwa, 616, Sultanate of Oman.
Ajmal KhanNatural and Medical Sciences Research Centre, University of Nizwa, Birkat Al Mauz, P.O. Box 33, Nizwa, 616, Sultanate of Oman.
Mariya Al-RashidaDepartment of Chemistry, Forman Christian College (A Chartered University, Lahore, Pakistan.
Talha IslamDepartment of Chemistry, Forman Christian College (A Chartered University, Lahore, Pakistan.
Kholood A DahlousDepartment of Chemistry, College of Science, King Saud University, Riyadh, 11451, Saudi Arabia.
Saikh MohammadDepartment of Chemistry, College of Science, King Saud University, Riyadh, 11451, Saudi Arabia.
Hamdy KashtohDepartment of Biotechnology, Yeungnam University, Gyeongsan, Gyeongbuk, 38541, Republic of Korea. hamdy_kashtoh@ynu.ac.kr.
Ahmed Al-HarrasiNatural and Medical Sciences Research Centre, University of Nizwa, Birkat Al Mauz, P.O. Box 33, Nizwa, 616, Sultanate of Oman. aharrasi@unizwa.edu.om.
Zahid ShafiqInstitute of Chemical Sciences, Bahauddin Zakariya University, Multan, 60800, Pakistan. zahidshafiq@bzu.edu.pk.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dihydrofolate reductase (DHFR), an essential enzyme in folate metabolism, presents a promising target for drug development against various diseases, including cancer and tuberculosis. Herein, we present an integrated approach combining in vitro biochemical assays with in silico molecular docking analysis to evaluate the inhibitory potential of 4-piperidine-based thiosemicarbazones 5(a-s) against DHFR. In our in vitro study, a novel series of 4-piperidine-based thiosemicarbazones 5(a-s) were assessed for their inhibitory activity against DHFR enzyme. The synthesized compounds 5(a-s) exhibited potent inhibition with IC

Indexed as

Drug DesignFolic Acid AntagonistsMolecular Docking SimulationPiperidinesTetrahydrofolate DehydrogenaseThiosemicarbazonesCatalytic DomainComputer SimulationHumansProtein BindingStructure-Activity RelationshipFolic Acid AntagonistspiperidinePiperidinesTetrahydrofolate DehydrogenaseThiosemicarbazonesADMEDHFREnzyme inhibitionMoLecular dockingPiperidineThiosemicarbazones

Identifiers

PMID39349528
PMCPMC11442999

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.